Home / Intelligence / Analyst Reports / Everest Group recognizes Trinity Life Sciences as a Featured Specialist in Operationalizing Generative AI in Life Sciences
Everest Group report:
AI-deas to Action: Operationalizing Generative AI in Life Sciences
This research report provides a comprehensive analysis of how generative AI (GenAI) is being operationalized in the life sciences industry and assesses the capabilities of the fifteen vendors included.
The report highlights several of Trinity’s key strengths, including:
Life Sciences Industry Expertise
Trinity has nearly 30 years of experience in the industry, providing evidence-based solutions to over 300 clients, including the global top 20 biopharma companies. This deep expertise translates siloed information into meaningful and effective insights.
Collaboration Between AI Technology and Human Experts
By embedding expert-driven feedback loops, Trinity enhances the accuracy and relevance of AI outputs, creating a collaborative environment where AI technology and human insights work together to drive efficiency, innovation and strategic decision‑making.
GenAI Tailored for the Life Sciences
The Trinity approach integrates cutting-edge GenAI models with domain-specific data to optimize GenAI for specific life sciences functions.
Access the report
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Trinity Life Sciences’ generative AI strategy blends foundational AI models with deep life sciences expertise, focusing on high-quality data, targeted functional optimization, and an expert-driven feedback loop. Through a value chain segment-based approach, particularly rooted in the sales and marketing segment, the company is working to drive meaningful AI adoption.
—Aastha Malik, Practice Director at Everest Group
Related Intelligence
Analyst Reports
Trinity Life Sciences Secures Prestigious Leader Position in Everest Group’s 2025 PEAK Matrix® for Life Sciences AI & Analytics Excellence
Trinity Life Sciences is a Leader in Everest Group’s 2025 Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment—with its distinction rooted in exceptional, tangible outcomes delivered for clients across the life sciences sector.
Read More
Blog
Empowering Field Teams: A Case Study in AI-Driven Call Planning
Field sales serve as the primary bridge between companies and healthcare professionals to build trust, provide valuable information and drive product adoption. Effective call planning is essential, as it allows reps to prioritize their engagements, tailor messaging and maximize their impact. The introduction of new technologies to streamline or enhance field operations comes with inherent […]
Read More
Webinars
The GenAI Advantage: Empowering Pharma Customer-Facing Teams
Available On Demand
Join us for the first webinar in our “AI Innovations in Life Sciences” series to learn how generative AI (GenAI) can transform the way customer-facing teams (sales reps and medical science liaisons) operate in life sciences companies. Discover practical applications of GenAI to enhance call planning and customer engagement and help field teams translate data […]
Watch Now